sibutramine has been researched along with Abnormalities, Multiple in 1 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Abnormalities, Multiple: Congenital abnormalities that affect more than one organ or body structure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Weight loss during pregnancy is therefore considered a risk factor." | 1.38 | Appetite suppressants in pregnancy. ( Hubičková Heringová, L; Kralova, T; Manakova, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manakova, E | 1 |
| Kralova, T | 1 |
| Hubičková Heringová, L | 1 |
1 other study available for sibutramine and Abnormalities, Multiple
| Article | Year |
|---|---|
Appetite suppressants in pregnancy.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Appetite Depressants; Cyclobutanes; Czech Republic; | 2012 |